NIH Awarded Grants for High-Risk Research Projects

Neeraj K. Lal and Kavita J. Rangan were among the recipients of the 2026 NIH Director's New Innovator Awards.

Updated on Oct. 12, 2026 in Life Sciences

NIH Awarded Grants for High-Risk Research Projects

Live Poll

Should the federal government prioritize funding for high-risk, innovative scientific research projects?

The National Institutes of Health has awarded 58 grants as part of its High-Risk, High-Reward Research program. The funding, totaling $237.5 million, includes prestigious New Innovator Awards for researchers Neeraj K. Lal and Kavita J. Rangan.

Why it matters

These awards provide crucial support for highly innovative projects that hold the potential to significantly advance biomedical and behavioral science. The grants target unconventional research approaches that might otherwise struggle to receive traditional funding.

The NIH awarded 42 New Innovator Awards as part of a $237.5 million initiative. Neeraj K. Lal specifically received $3.8 million in funding to support his five-year study on Arctic ground squirrel hibernation.

The players

Neeraj K. Lal

He is a researcher focused on developing methodologies to study the biology of Arctic ground squirrels.

Kavita J. Rangan

She is an investigator working on RNA recoding and the development of open-access tools for genomic research.

National Institutes of Health

This is the primary federal agency responsible for biomedical and public health research in the United States.

The details

Neeraj K. Lal is developing new genetic tools to investigate biological mechanisms in Arctic ground squirrels, while Kavita J. Rangan is building an open-access resource called Recoding Explorer to map RNA editing sites. These projects aim to uncover fundamental biological processes, such as how RNA recoding influences genome maintenance.

2007: The NIH Director's New Innovator Award program was established.
2026: The NIH announced the latest cohort of award recipients.

The Big Picture

This story tracks the latest funding cycle of the NIH High-Risk, High-Reward Research program. The awards mark a continued commitment to high-stakes scientific inquiry that bridges gaps in current biomedical knowledge.

The research funded by these grants may lead to future medical treatments or a deeper understanding of biological processes relevant to human health. While these projects are currently in the academic stage, they are designed to form the basis for long-term technological and medical advancements.

The takeaway

The NIH continues to prioritize experimental research that targets complex biological questions. Readers can note that these long-term studies often serve as the foundation for the next decade of medical innovation.